A Clinical Study of Cizutamig in Thyroid Eye Disease

Clinical trial NCT07597200 · RECRUITING

Trial details

NCT number: NCT07597200
Sponsor: Candid Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Thyroid Eye Disease, TED

Start date: 2026-05-08
Primary completion: 2028-05-31
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.